Expanding the Genetic Spectrum of AGXT Gene Variants in Egyptian Patients with Primary Hyperoxaluria Type I
Genetic Testing and Molecular Biomarkers · 2024
DOI: 10.1089/gtmb.2023.0525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2024. Verfasst von Somayya Naguib und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Chemical Pathology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Hyperoxaluria, Primary, Transaminases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Introduction
Approximately 80% of primary hyperoxaluria cases are caused by primary hyperoxaluria type 1 (PH1, OMIM# 259900), which is characterized by pathogenic variants in the AGXT gene, resulting in deficiency of the liver-specific enzyme alanine-glyoxylate aminotransferase (AGT). This leads to increased production of oxalate, which cannot be effectively eliminated from the body, resulting in its accumulation primarily in the kidneys and other organs. Subjects and Methods: This study included 17 PH1 Egyptian patients from 12 unrelated families, recruited from the Inherited Kidney Disease Outpatient Clinic and the Dialysis Units, Cairo University Hospitals, during the period from January 2018 to December 2019, aiming to identify the pathogenic variants in the AGXT gene.
Results
Six different variants were detected. These included three frameshift and three missense variants, all found in homozygosity within the respective families. The most common variant was c.121G>A;p.(Gly41Arg) detected in four families, followed by c.725dup;p.(Asp243GlyfsTer12) in three families, c.33dup;p.(Lys12Glnfs156) in two families, and c.731T >C;p.(Ile244Thr), c.33delC;p.(Lys12Argfs34), and c.568G>A;p.(Gly190Arg) detected in one family each.
Conclusion
Consanguineous Egyptian families with history of renal stones or renal disease suspicious of primary hyperoxaluria should undergo AGXT genetic sequencing, specifically targeting exons 1 and 7, as variants in these two exons account for >75% of disease-causing variants in Egyptian patients with confirmed PH1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Chemical Pathology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Pediatrics, Center of Pediatric Nephrology and Transplantation (CPNT), Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
- Egyptian Group for Orphan Renal Disease (EGORD), Cairo, Egypt.
- Department of Clinical Genetics, Egypt Center for Research and Regenerative Medicine (ECRRM), Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
- Department of Clinical and Chemical Pathology, Faculty of Medicine, New Giza University, Giza, Egypt.
ORCID-Profile: Somayya Naguib, Mohamed A Elmonem
Zitieren
APA
Naguib, S., Mansour, L. A., Soliman, N. A., El-Hanafy, H. M., Fahmy, Y. A., Elmonem, M. A., & Halim, R. M. A. (2024). Expanding the Genetic Spectrum of AGXT Gene Variants in Egyptian Patients with Primary Hyperoxaluria Type I. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2023.0525
Vancouver
Naguib S, Mansour LA, Soliman NA, El-Hanafy HM, Fahmy YA, Elmonem MA, et al. Expanding the Genetic Spectrum of AGXT Gene Variants in Egyptian Patients with Primary Hyperoxaluria Type I. Genetic Testing and Molecular Biomarkers. 2024. doi:10.1089/gtmb.2023.0525
BibTeX
@article{Naguib2024,
author = {Naguib, Somayya and Mansour, Lamiaa A and Soliman, Neveen A and El-Hanafy, Hadeel M and Fahmy, Yosra A and Elmonem, Mohamed A and Halim, Radwa M Abdel},
title = {Expanding the Genetic Spectrum of AGXT Gene Variants in Egyptian Patients with Primary Hyperoxaluria Type I},
journal = {Genetic Testing and Molecular Biomarkers},
year = {2024},
doi = {10.1089/gtmb.2023.0525}
}
EUVIMED